Ming‐Feng Wei
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 5%
Papers in
-
- Advanced biosensing and bioanalysis techniques 8
- RNA Interference and Gene Delivery 7
-
- Polyoxometalates: Synthesis and Applications 6
- Covalent Organic Framework Applications 4
- Co-authors
- Ming‐Jium Shieh (10 shared papers)Shu‐Jyuan Yang (4 shared papers)Feng‐Huei Lin (5 shared papers)Han-Min Tsai (1 shared paper)Kun‐Che Tsai (1 shared paper)Jau‐Min Wong (1 shared paper)Ke-Cheng Chen (2 shared papers)Cheng-Jung Yao (2 shared papers)
- Journals
- Biomaterials (3 papers)Nano Letters (2 papers)Cancer Cell International (2 papers)ACS Applied Materials & Interfaces (2 papers)Chemical Communications (2 papers)
- Partner nations
- TaiwanChinaUnited States
In The Last Decade
Ming‐Feng Wei
42 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 109
- Biomaterials 365
- Pharmaceutical Science 84
- Molecular Medicine 50
- Biomedical Engineering 450
- Cancer Research 127
Countries citing papers authored by Ming‐Feng Wei
This map shows the geographic impact of Ming‐Feng Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming‐Feng Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming‐Feng Wei more than expected).
Fields of papers citing papers by Ming‐Feng Wei
This network shows the impact of papers produced by Ming‐Feng Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming‐Feng Wei. The network helps show where Ming‐Feng Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Ming‐Feng Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 273 | |
| 2 | 2010 | 263 | |
| 3 | 2014 | 179 | |
| 4 | 2016 | 99 | |
| 5 | 2016 | 93 | |
| 6 | 2007 | 92 | |
| 7 | 2008 | 49 | |
| 8 | 2014 | 46 | |
| 9 | 2023 | 46 | |
| 10 | 2022 | 43 | |
| 11 | 2017 | 41 | |
| 12 | 2005 | 36 | |
| 13 | 2022 | 31 | |
| 14 | 2022 | 28 | |
| 15 | 2013 | 27 | |
| 16 | 2021 | 20 | |
| 17 | 2017 | 19 | |
| 18 | 2024 | 16 | |
| 19 | 2014 | 15 | |
| 20 | 2016 | 13 |
About Ming‐Feng Wei
Ming‐Feng Wei is a scholar working on Molecular Biology, Materials Chemistry, Inorganic Chemistry, Biomaterials and Pulmonary and Respiratory Medicine, having authored 47 papers that have together received 1.6k indexed citations. Recurring topics across this work include Metal-Organic Frameworks: Synthesis and Applications (8 papers), Advanced biosensing and bioanalysis techniques (8 papers), RNA Interference and Gene Delivery (7 papers), Polyoxometalates: Synthesis and Applications (6 papers), Advanced Photocatalysis Techniques (4 papers), Covalent Organic Framework Applications (4 papers), Virus-based gene therapy research (4 papers) and Nanoparticle-Based Drug Delivery (4 papers). The work is most often cited by research in Biomaterials (365 citations), Pharmaceutical Science (84 citations), Molecular Medicine (50 citations), Biomedical Engineering (450 citations) and Cancer Research (127 citations). Ming‐Feng Wei has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Ming‐Jium Shieh, Shu‐Jyuan Yang, Feng‐Huei Lin, Han-Min Tsai, Kun‐Che Tsai, Jau‐Min Wong, Ke-Cheng Chen, Cheng-Jung Yao, Lixin Wu and Bao Li. Their work appears in journals such as Biomaterials, Nano Letters, Cancer Cell International, ACS Applied Materials & Interfaces and Chemical Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.